Treatment Options for Helicobacter Pylori and Peptic Ulcer Disease Active Helicobacter pylori—associated ulcer 1. Treat with anti—H pylori regimen for 14 days. Treatment options: Standard Bismuth Quadruple Therapy • Proton pump inhibitor orally twice daily • Bismuth subsalicylate two tablets orally four times daily • Tetracycline 500 mg orally four times daily • Metronidazole 500 mg three times daily (OR bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline 125 mg three capsules orally four times daily) Standard Nonbismuth Quadruple Therapy • Proton pump inhibitor orally twice daily • Amoxicillin 1000 mg twice daily • Metronidazole 500 mg twice daily • Clarithromycin 500 mg twice daily Standard Triple Therapy (No longer recommended except in locales where clarithromycin resistance is < 15%) • Proton pump inhibitor twice daily • Clarithromycin 500 mg twice daily • Amoxicillin 1 g orally twice daily (or, if penicillin allergic, metronidazole 500 mg orally twice daily) 2. After completion of course of H pylori eradication therapy, continue treatment with proton pump inhibitorl once daily for 4-6 weeks if ulcer is large (> I cm) or complicated. 3. Confirm successful eradication of H pylori with urea breath test, fecal antigen test, or endoscopy with biopsy at least 4 weeks after completion of antibiotic treatment and 1—2 weeks after proton pump inhibitor treatment. Active ulcer not attributable to H pylori Consider other causes: NSAIDs, Zollinger-EIIison syndrome, gastric malignancy. Treatment options: • Proton pump inhibitors: - Uncomplicated duodenal ulcer: treat for 4 weeks - Uncomplicated gastric ulcer: treat for 8 weeks • H2-receptor antagonists: - Uncomplicated duodenal ulcer: cimetidine 800 mg, ranitidine or nizatidine 300 mg, famotidine 40 mg, orally once daily at bedtime for 6 weeks - Uncomplicated gastric ulcer: cimetidine 400 mg, ranitidine or nizatidine 150 mg, famotidine 20 mg, orally twice daily for 8 weeks - Complicated ulcers: proton pump inhibitors are the preferred drugs #Helicobacter #HPylori #PepticUlcerDisease #PUD #Treatment #Management #Pharmacology #Medications